Coronavirus Updates

As a global health service company dedicated to improving the health, well-being and peace of mind of those we serve, Cigna is committed to bringing the latest and useful information around COVID-19 to the world.

COVID-19 Vaccines

In response to the COVID-19 pandemic, scientists from across the globe have worked tirelessly to develop and test vaccines at an unprecedented speed in an effort to manage the ongoing crisis and end the pandemic. With numerous vaccines now approved, available and being administered to global populations, we have reason to be hopeful about a future return to pre-pandemic routines.

  • We are committed to providing those we serve with the latest information on the global vaccination efforts currently underway.
  • This includes sharing insights from Cigna's ongoing study of global attitudes about COVID-19 vaccines and educational materials designed to help you learn more about vaccine development, efficacy and effects.
  • For questions about your Cigna policy terms or COVID-19 vaccination coverage, please contact your Cigna representative.

Cigna's Vaccine Study

We are actively supporting our customers, clients and partners with relevant and accurate information about the COVID-19 inoculation program across the world.  Since March 2021 we have engaged with over 39,000 respondents in China, Hong Kong, New Zealand, Singapore, South Korea, Spain, Taiwan, Thailand, UAE, UK and USA to understand their attitudes to the vaccination program and inform future communication.

Attitudes to vaccination continued to improve and vaccine hesitancy has reduced significantly.

Download the Report

Vaccine acceptance grew significantly, although there remained significant differences between markets and generations.

Download the Report

While people were following the news of the vaccines very closely, many felt they did not know enough to make an informed decision – with many opting for a ‘Wait and See’ approach.

Download the report

Educational materials & thought leadership



Why COVID vaccines are necessary?

Vaccines save millions of lives every year. The COVID-19 vaccines are designed to protect us against this particular virus and save lives.

APR 2021 | NEWS

COVID-19 puts vaccine hesitancy in the spotlight

Any vaccine program relies on access and people’s willingness to be immunized. But for some there is a reluctance and this ‘vaccine hesistancy’ can impact the success of new vaccines.


Accessing reliable information about the COVID-19 vaccines

Accurate information about the COVID-19 vaccines enables us to make an informed decision about having a vaccination.


Understanding efficacy levels of the COVID-19 vaccines

The new COVID-19 vaccines have been produced at record speed due to unparalleled investment and global scientific collaboration.


How the COVID-19 vaccines were created so quickly

There are various factors that have helped the global medical community to create effective vaccines that can be used to protect the population from COVID-19.


What are the COVID-19 vaccine side effects

When you are vaccinated, your body responds by preparing to protect itself. Side effects are a sign that your body is beginning to build immunity.


COVID-19 vaccines for women of childbearing age

No concerns about the vaccines and safety in pregnancy have been raised by the World Health Organization or regulatory bodies in the US, Canada, UK, or Europe.

Additional resources

For more information on the COVID-19 vaccine, please refer to the following helpful resources:

Related content


APR 2021 | NEWS

COVID Global Impact Report 5

Since the start of the pandemic, Cigna has been tracking five areas of people’s lives that influence their well-being including family, financial, physical, social and work in our COVID-19 Global Impact Study.
Read more

JUN 2021 | 360 WELL-BEING

COVID-19 is stressing us out. Here’s what you need to know

It’s no secret that our well-being has taken a hit with the coronavirus pandemic. In the Cigna 360 Well-Being Survey, one of the longest longitudinal studies of its kind, we unsurprisingly found indices trending below what we saw pre-pandemic.
Read more

Need any help? We’d love to hear from you.

Our expert advisors are on hand to help. Contact us, we are here to answer your questions.